A survey of 501 specialty pharmacists and prescribers from the health information technology company Surescripts investigated why there are frequent delays in starting patients on new therapies. Although more than 80% of specialty pharmacists and prescribers believed this process should take two weeks or less, fewer than one-third of the respondents said it currently takes that amount of time.
The data revealed that respondents viewed obtaining prior authorization as the top